Literature DB >> 16483187

Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines.

K Miehle, J Kratzsch, J W M Lenders, R Kluge, R Paschke, C A Koch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16483187     DOI： 10.1007/BF03345347

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  11 in total

1.  A critical evaluation of simple methods for the estimation of free testosterone in serum.

Authors:  A Vermeulen; L Verdonck; J M Kaufman
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

Review 2.  The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.

Authors:  K Filipsson; M Kvist-Reimer; B Ahrén
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

3.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

4.  Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.

Authors:  S Sanduleanu; M Stridsberg; D Jonkers; W Hameeteman; I Biemond; G Lundqvist; C Lamers; R W Stockbrügger
Journal:  Aliment Pharmacol Ther       Date:  1999-02       Impact factor: 8.171

5.  Clinical significance of elevated serum chromogranin A levels.

Authors:  U Syversen; H Ramstad; K Gamme; G Qvigstad; S Falkmer; H L Waldum
Journal:  Scand J Gastroenterol       Date:  2004-10       Impact factor: 2.423

6.  Plasma and tissue chromogranin in patients with adrenocortical adenomas.

Authors:  G P Bernini; A Moretti; M Borgioli; M Bardini; P Miccoli; P Berti; F Basolo; P Faviana; R Birindelli; A Salvetti
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

7.  Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.

Authors:  D Nehar; C Lombard-Bohas; S Olivieri; B Claustrat; J-A Chayvialle; M-C Penes; G Sassolas; F Borson-Chazot
Journal:  Clin Endocrinol (Oxf)       Date:  2004-05       Impact factor: 3.478

8.  Immunoluminometric assay of chromogranin A in serum with commercially available reagents.

Authors:  H Bender; A Maier; B Wiedenmann; D T O'Connor; K Messner; H Schmidt-Gayk
Journal:  Clin Chem       Date:  1992-11       Impact factor: 8.327

9.  Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.

Authors:  R J Hsiao; R J Parmer; M A Takiyyuddin; D T O'Connor
Journal:  Medicine (Baltimore)       Date:  1991-01       Impact factor: 1.889

10.  Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma.

Authors:  L Giovanella; L Ceriani
Journal:  Int J Biol Markers       Date:  2002 Apr-Jun       Impact factor: 3.248
View more
  1 in total

1.  Ultrasound imaging in the diagnosis of benign and suspicious adrenal lesions.

Authors:  Jin Fan; Jie Tang; Jiabin Fang; Qiuyang Li; Enhui He; Jia Li; Yanqiu Wang
Journal:  Med Sci Monit       Date:  2014-11-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.